Orange Book product · Generic (ANDA)
NATEGLINIDE
NATEGLINIDE
At a glance
Jul 06, 2016
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 06, 2016
10 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
NATEGLINIDE
Strength
60MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 205248
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of NATEGLINIDE
- 2000STARLIXBrand (NDA)
NDA 021204 · NOVARTIS
- 2019NATEGLINIDEGeneric (ANDA)
ANDA 206432 · CADILA PHARMS LTD
- 2018NATEGLINIDEGeneric (ANDA)
ANDA 205544 · RISING
- 2015NATEGLINIDEGeneric (ANDA)
ANDA 205055 · ALVOGEN
- 2011NATEGLINIDEGeneric (ANDA)
ANDA 077462 · WATSON LABS
- 2009NATEGLINIDEGeneric (ANDA)
ANDA 077461 · DR REDDYS LABS LTD
- 2009NATEGLINIDEGeneric (ANDA)
ANDA 077463 · STRIDES PHARMA INTL
- 2009NATEGLINIDEGeneric (ANDA)
ANDA 077467 · TEVA PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
